Livzon Pharmaceutical Group Inc. | Cash Flow
Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
661
697
814
970
5,175
1,400
Depreciation, Depletion & Amortization
227
324
396
437
432
452
Other Funds
46
86
215
1,570
306
103
Funds from Operations
937
1,134
1,296
1,484
622
1,968
Changes in Working Capital
381
226
151
12
914
462
Net Operating Cash Flow
556
908
1,145
1,496
1,537
1,506
Capital Expenditures
1,161
838
589
431
339
Sale of Fixed Assets & Businesses
65
127
69
210
5,186
Purchase/Sale of Investments
58
105
100
786
541
Net Investing Cash Flow
1,040
811
629
989
5,386
Cash Dividends Paid - Total
187
186
38
232
-
Issuance/Reduction of Debt, Net
141
123
624
351
379
Net Financing Cash Flow
92
150
449
982
690
Net Change in Cash
576
53
72
1,513
6,156
Free Cash Flow
605
71
556
1,066
1,197
Deferred Taxes & Investment Tax Credit
8
1
55
51
35
14
Other Sources
9
15
18
17
-
Change in Capital Stock
-
-
2
6
4
Exchange Rate Effect
1
-
4
23
77
About Livzon Pharmaceutical Group
View Profile
